AlpHelix Biosciences is a high-tech biotech company that contributes to the discovery of innovative biopharmaceuticals. We focus on membrane proteins (including ion channels, transporters, and GPCRs) and challenging Kinases. The main services of AlpHelix include overexpression and purification of membrane proteins, biophysical and biochemical characterization of these proteins, high-throughput ligand/drug screening using report cells, monoclonal/bispecific antibody discovery and engineering based on yeast surface display of full-length IgG, structure determination using X-ray crystallography and cryo-electron microscopy, and drug discovery and optimization based on the protein structures.

AlpHelix has built advanced technology platforms such as "structural biology," "cell engineering," "antibody and new chemical entity discovery," and "functional verification," and has established cooperative relationships with many well-known pharmaceutical companies and biotechnology companies to conduct research and development collaborations on small molecule, antibody, and peptide drugs targeting GPCRs, ion channels, and transporters.